NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Samsara Therapeutics

Samsara Therapeutics

Private
OxfordHealthcare & Life Scienceshttps://samsaratherapeutics.com/

Last Round

Grant

Oct 28, 2024

Total Funding Raised

$29.1M

Company Overview

Samsara Therapeutics is a biotechnology company that develops small-molecule autophagy activators to treat age-related neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug discoveryautophagysmall-molecule drugsneurodegenerative diseasebiotechphenotypic screeningiPSCinduced pluripotent stem cellscellular recyclingparkinson's researchtherapeutic pipelinedrug developmentbiotech startupmedicinal chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Samsara Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Samsara Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Samsara Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 28, 2024
GrantNov 1, 2023
GrantJun 12, 2023
GrantOct 12, 2022
SeedDec 20, 2019

Samsara Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 20, 2019

    $3.2M raised from Kite Ventures and others.

Samsara Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Samsara Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Samsara Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford
Employee Range13
Year Founded2019
Last FundingOct 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.